Yurie Oka, Jun Matsumoto, Tatsuaki Takeda, Naohiro Iwata, Takahiro Niimura, Aya Fukuma Ozaki, Kensuke Bekku, Hirofumi Hamano, Motoo Araki, Keisuke Ishizawa, et al. Adverse Events of Nivolumab plus Ipilimumab versus Nivolumab plus Cabozantinib: A Real-World Pharmacovigilance Study. International Journal of Clinical Pharmacy. 2024
Tatsuaki Takeda, Shiho Sugimoto, Jun Matsumoto, Naohiro Iwata, Akihiko Nakamoto, Aya Fukuma Ozaki, Hirofumi Hamano, Noritaka Ariyoshi, Yoshito Zamami. A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases. International Journal of Clinical Pharmacy. 2024
Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combination. 2023. 3. 1-8
Jun Matsumoto, Madoka Itano, Naohiro Iwata, Masafumi Oro, Chikako Kitakaze, Ayuko Hirota, Katsuhiko Makino, Tomoyuki Tateno, Ryohei Terai, Hideo Kenmotsu, et al. Awareness about the Establishment of Clinical Evidence among Community Pharmacists: A Large-scale Survey among Members of the Okayama Pharmaceutical Association. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 2023. 143. 4. 393-404